GeneDx Holdings Corp.
Status: Publicly traded
Last reviewed: October 2026
Direct answer
GeneDx Holdings Corp. is publicly traded on NASDAQ under the ticker WGS.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx...
Can you invest in GeneDx Holdings Corp.?
Yes. GeneDx Holdings Corp. trades publicly on NASDAQ as WGS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for GeneDx Holdings Corp.
Detailed equity research is provided by MarketSnap.